Enzyme polymorphisms influencing the metabolism of heterocyclic aromatic amines

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 802, Issue 1, 2004, Pages 175-181

  Airoldi, Luisa ^a   Magagnotti, Cinzia ^a   Pastorelli, Roberta ^a   Fanelli, Roberto ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Enzyme polymorphisms; Heterocyclic aromatic amines metabolism

Indexed keywords

AMINES; CARCINOGENS; DETOXIFICATION; DNA; EPIDEMIOLOGY; GENES; METABOLISM; TUMORS;

MULTISTAGE PROCESSES; POLYMORPHISM;

ENZYMES;

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; BIOLOGICAL MARKER; CARCINOGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; ENZYME; GLUTATHIONE TRANSFERASE; HETEROCYCLIC AMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ALLELE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLON CANCER; COOKING; DETOXIFICATION; DIET; DNA ADDUCT; DNA BINDING; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; ENZYME ACTIVITY; ENZYME POLYMORPHISM; EPIDEMIOLOGICAL DATA; FOOD INTAKE; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; GENOTOXICITY; GENOTYPE; GLUCURONIDATION; HUMAN; IN VITRO STUDY; LIVER; LIVER MICROSOME; MALIGNANT NEOPLASTIC DISEASE; MEAT; METABOLIC ACTIVATION; METABOLISM; METABOLITE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; URINARY EXCRETION;

EID: 1242283912     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2003.10.055     Document Type: Article

References (96)

1. Sugimura T. Mutat. Res. 376:1997;211.
2. Skog K.I., Johansson M.A., Jagerstad M.I. Food Chem. Toxicol. 36:1998;879.
3. Wakabayashi K., Nagao M., Esumi H., Sugimura T. Cancer Res. 52:1992;2092s.
4. Stillwell W.G., Sinha R., Tannenbaum S.R. Carcinogenesis. 23:2002;831.
5. Stillwell W.G., Turesky R.J., Sinha R., Skipper P.L., Tannenbaum S.R. Cancer Lett. 143:1999;145.
6. Stillwell W.G., Kidd L.C., Wishnok J.S., Tannenbaum S.R., Sinha R. Cancer Res. 57:1997;3457.
7. Malfatti M.A., Kulp K.S., Knize M.G., Davis C., Massengill J.P., Williams S., Nowell S., MacLeod S., Dingley K.H., Turteltaub K.W., Lang N.P., Felton J.S. Carcinogenesis. 20:1999;705.
8. Potter J.D. J. Natl. Cancer Inst. 91:1999;916.
9. Kampman E., Slattery M.L., Bigler J., Leppert M., Samowitz W., Caan B.J., Potter J.D. Cancer Epidemiol. Biomarkers Prev. 8:1999;15.
10. Sinha R., Gustafson D.R., Kulldorff M., Wen W.Q., Cerhan J.R., Zheng W. J. Natl. Cancer Inst. 92:2000;1352.
11. Zheng W., Gustafson D.R., Sinha R., Cerhan J.R., Moore D., Hong C.P., Anderson K.E., Kushi L.H., Sellers T.A., Folsom A.R. J. Natl. Cancer Inst. 90:1998;1724.
12. Anderson K.E., Sinha R., Kulldorff M., Gross M., Lang N.P., Barber C., Harnack L., DiMagno E., Bliss R., Kadlubar F.F. Mutat. Res. 506-507:2002;225.
13. Michaud D.S., Augustsson K., Rimm E.B., Stampfer M.J., Willet W.C., Giovannucci E. Cancer Causes Control. 12:2001;557.
14. Augustsson K., Skog K., Jagerstad M., Dickman P.W., Steineck G. Lancet. 353:1999;703.
15. Norrish A.E., Ferguson L.R., Knize M.G., Felton J.S., Sharpe S.J., Jackson R.T. J. Natl. Cancer Inst. 91:1999;2038.
16. Schut H.A., Snyderwine E.G. Carcinogenesis. 20:1999;353.
17. Boobis A.R., Lynch A.M., Murray S., de la Torre R., Solans A., Farré M., Segura J., Gooderham N.J., Davies D.S. Cancer Res. 54:1994;89.
18. Crofts F.G., Strickland P.T., Hayes C.L., Sutter T.R. Carcinogenesis. 18:1997;1793.
19. Crofts F.G., Sutter T.R., Strickland P.T. Carcinogenesis. 19:1998;1969.
20. Hammons G.J., Milton D., Stepps K., Guengerich F.P., Tukey R.H.K., Kadlubar F.F. Carcinogenesis. 18:1997;851.
21. Coles B., Ketterer B. Crit. Rev. Biochem. Mol. Biol. 25:1990;47.
22. Miners J.O., McKinnon R.A., Mackenzie P.I. Toxicology. 181-182:2002;453.
23. P. Vineis, N. Malatas, M. Lang, A. D'Errico, N. Caporaso, J. Cuzick, P. Boffetta, Metabolic Polymophisms and Susceptibility to Cancer, International Agency for Research on Cancer, Lyon, 1999.
24. Landi M.T., Sinha R., Lang N.P., Kadlubar F.F. IARC Sci. Publ. 148:1999;173.
25. Sachse C., Brockmoller J., Bauer S., Roots I. Br. J. Clin. Pharmacol. 47:1999;445.
26. Welfare M.R., Aitkin M., Bassendine M.F., Daly A.K. Pharmacogenetics. 9:1999;367.
27. Lang N.P., Butler M.A., Massengill J., Lawson M., Stotts R.C., Hauer Jensen M., Kadlubar F.F. Cancer Epidemiol. Biomarkers Prev. 3:1994;675.
28. Le Marchand L., Hankin J.H., Wilkens L.R., Pierce L.M., Franke A., Kolonel L.N., Seifried A., Custer L.J., Chang W., Lum-Jones A., Donlon T. Cancer Epidemiol. Biomarkers Prev. 10:2001;1259.
29. Williams J.A., Phillips D.H. Cancer Res. 60:2000;4667.
30. Kawajiri K. IARC Sci. Publ. 148:1999;159.
31. Crofts F., Taioli E., Trachman J., Cosma G.N., Currie D., Garte S.J. Carcinogenesis. 15:1994;2961.
32. MacLeod S., Sinha R., Kadlubar F.F., Lang N.P. Mutat. Res. 376:1997;135.
33. Watanabe J., Shimada T., Gillam E.M., Ikuta T., Suemasu K., Higashi Y., Gotoh O., Kawajiri K. Pharmacogenetics. 10:2000;25.
34. Zheng W., Xie D.W., Jin F., Cheng J.R., Dai Q., Wen W.Q., Shu X.O., Gao Y.T. Cancer Epidemiol. Biomarkers Prev. 9:2000;147.
35. Tanaka Y., Sasaki M., Kaneuchi M., Shiina H., Igawa M., Dahiya R. Biochem. Biophys. Res. Commun. 296:2002;820.
36. Grant D.M., Hughes N.C., Janezic S.A., Goodfellow G.H., Chen H.J., Gaedigk A., Yu V.L., Grewal R. Mutat. Res. 376:1997;61.
37. Hein D.W., Doll M.A., Fretland A.J., Leff M.A., Webb S.J., Xiao G.H., Devanaboyina U.S., Nangju N.A., Feng Y. Cancer Epidemiol. Biomarkers Prev. 9:2000;29.
38. Cascorbi I., Brockmoller J., Mrozikiewicz P.M., Muller A., Roots I. Drug Metab. Rev. 31:1999;489.
39. Bruhn C., Brockmoller J., Cascorbi I., Roots I., Borchert H.H. Biochem. Pharmacol. 58:1999;1759.
40. Slattery M.L., Potter J.D., Ma K.N., Caan B.J., Leppert M., Samowitz W. Cancer Causes Control. 11:2000;1.
41. Sachse C., Smith G., Wilkie M.J., Barrett J.H., Waxman R., Sullivan F., Forman D., Bishop D.T., Wolf C.R. Carcinogenesis. 23:2002;1839.
42. Butler W.J., Ryan P., Roberts-Thomson I.C. J. Gastroenterol. Hepatol. 16:2001;631.
43. Gil J.P., Lechner M.C. Carcinogenesis. 19:1998;37.
44. Barrett J.H., Smith G., Waxman R., Gooderham N., Lightfoot T., Garner R.C., Augustsson K., Wolf C.R., Bishop D.T., Forman D. Carcinogenesis. 24:2003;275.
45. Deitz A.C., Zheng W., Leff M.A., Gross M., Wen W.Q., Doll M.A., Xiao G.H., Folsom A.R., Hein D.W. Cancer Epidemiol. Biomarkers Prev. 9:2000;905.
46. Delfino R.J., Sinha R., Smith C., West J., White E., Lin H.J., Liao S.Y., Gim J.S., Ma H.L., Butler J., Anton-Culver H. Carcinogenesis. 21:2000;607.
47. Gertig D.M., Hankinson S.E., Hough H., Spiegelman D., Colditz G.A., Willett W.C., Kelsey K.T., Hunter D.J. Int. J. Cancer. 80:1999;13.
48. Bell D.A., Stephens E.A., Castranio T., Umbach D.M., Watson M., Deakin M., Elder J., Hendrickse C., Duncan H., Strange R.C. Cancer Res. 55:1995;3537.
49. Probst-Hensch N.M., Haile R.W., Li D.S., Sakamoto G.T., Louie A.D., Lin B.K., Frankl H.D., Lee E.R., Lin H.J. Carcinogenesis. 17:1996;2125.
50. Glatt H. Chem. Biol. Interact. 129:2000;141.
51. Meinl W., Meerman J.H., Glatt H. Pharmacogenetics. 12:2002;677.
52. Raftogianis R.B., Wood T.C., Otterness D.M., Van Loon J.A., Weinshilboum R.M. Biochem. Biophys. Res. Commun. 239:1997;298.
53. Coughtrie M.W., Gilissen R.A., Shek B., Strange R.C., Fryer A.A., Jones P.W., Bamber D.E. Biochem. J. 337:1999;45.
54. Carlini E.J., Raftogianis R.B., Wood T.C., Jin F., Zheng W., Rebbeck T.R., Weinshilboum R.M. Pharmacogenetics. 11:2001;57.
55. Ozawa S., Chou H.C., Kadlubar F.F., Nagata K., Yamazoe Y., Kato R. Jpn. J. Cancer Res. 85:1994;1220.
56. Yamazoe Y., Nagata K., Yoshinari K., Fujita K., Shiraga T., Iwasaki K. Cancer Lett. 143:1999;103.
57. Windmill K.F., Christiansen A., Teusner J.T., Bhasker C.R., Birkett D.J., Zhu X., McManus M.E. Chem. Biol. Interact. 109:1998;341.
58. Bamber D.E., Fryer A.A., Strange R.C., Elder J.B., Deakin M., Rajagopal R., Fawole A., Gilissen R.A., Campbell F.C., Coughtrie M.W. Pharmacogenetics. 11:2001;679.
59. Nowell S., Coles B., Sinha R., MacLeod S., Luke Ratnasinghe D., Stotts C., Kadlubar F.F., Ambrosone C.B., Lang N.P. Mutat. Res. 506-507:2002;175.
60. Zheng W., Xie D., Cerhan J.R., Sellers T.A., Wen W., Folsom A.R. Cancer Epidemiol. Biomarkers Prev. 10:2001;89.
61. Steiner M., Bastian M., Schulz W.A., Pulte T., Franke K.H., Rohring A., Wolff J.M., Seiter H., Schuff-Werner P. Arch. Toxicol. 74:2000;222.
62. Lin D.X., Meyer D.J., Ketterer B., Lang N.P., Kadlubar F.F. Cancer Res. 54:1994;4920.
63. Kaderlik K.R., Mulder G.J., Shaddock J.G., Casciano D.A., Teitel C.H., Kadlubar F.F. Carcinogenesis. 15:1994;1711.
64. Hayes J.D., Strange R.C. Pharmacology. 61:2000;154.
65. Coles B.F., Morel F., Rauch C., Huber W.W., Yang M., Teitel C.H., Green B., Lang N.P., Kadlubar F.F. Pharmacogenetics. 11:2001;663.
66. Coles B., Nowell S.A., MacLeod S.L., Sweeney C., Lang N.P., Kadlubar F.F. Mutat. Res. 482:2001;3.
67. Ye Z., Parry J.M. Teratog. Carcinog. Mutagen. 22:2002;385.
68. Gertig D.M., Stampfer M., Haiman C., Hennekens C.H., Kelsey K., Hunter D.J. Cancer Epidemiol. Biomarkers Prev. 7:1998;1001.
69. Zhong S., Wyllie A.H., Barnes D., Wolf C.R., Spurr N.K. Carcinogenesis. 14:1993;1821.
70. Nowell S.A., Massengill J.S., Williams S., Radominska-Pandya A., Tephly T.R., Cheng Z., Strassburg C.P., Tukey R.H., MacLeod S.L., Lang N.P., Kadlubar F.F. Carcinogenesis. 20:1999;1107.
71. Lampe J.W., Bigler J., Horner N.K., Potter J.D. Pharmacogenetics. 9:1999;341.
72. Malfatti M.A., Felton J.S. Carcinogenesis. 22:2001;1087.
73. Strassburg C.P., Manns M.P., Tukey R.H. J. Biol. Chem. 273:1998;8719.
74. Strassburg C.P., Vogel A., Kneip S., Tukey R.H., Manns M.P. Gut. 50:2002;851.
75. Sundberg A.G., Nilsson R., Appelkvist E.L., Dallner G. Pharmacol. Toxicol. 72:1993;321.
76. Stone E.M., Williams J.A., Grover P.L., Gusterson B.A., Phillips D.H. Carcinogenesis. 19:1998;873.
77. Nelson C.P., Kidd L.C., Sauvageot J., Isaacs W.B., De Marzo A.M., Groopman J.D., Nelson W.G., Kensler T.W. Cancer Res. 61:2001;103.
78. Turesky R.J., Constable A., Richoz J., Varga N., Markovic J., Martin M.V., Guengerich F.P. Chem. Res. Toxicol. 11:1998;925.
79. Snyderwine E.G., Yu M., Schut H.A., Knight-Jones L., Kimura S. Food Chem. Toxicol. 40:2002;1529.
80. Hein D.W., Doll M.A., Rustan T.D., Gray K., Ferguson R.J., Feng Y. Toxicol. Appl. Pharmacol. 124:1994;16.
81. Fretland A.J., Devanaboyina U.S., Feng Y., Leff M.A., Xiao G.H., Webb S.J., Hein D.W. Toxicol. Sci. 59:2001;226.
82. Muckel E., Frandsen H., Glatt H.R. Food Chem. Toxicol. 40:2002;1063.
83. Steffensen I.L., Fretland A.J., Paulsen J.E., Feng Y., Eide T.J., Devanaboyina U.S., Hein D.W., Alexander J. Pharmacol. Toxicol. 86:2000;257.
84. Purewal M., Fretland A.J., Schut H.A., Hein D.W., Wargovich M.J. Cancer Lett. 149:2000;53.
85. Purewal M., Velasco M., Fretland A.J., Hein D.W., Wargovich M.J. Cancer Epidemiol. Biomarkers Prev. 9:2000;529.
86. Pfau W., Stone E.M., Brockstedt U., Carmichael P.L., Marquardt H., Phillips D.H. Cancer Epidemiol. Biomarkers Prev. 7:1998;1019.
87. Brockstedt U., Krajinovic M., Richer C., Mathonnet G., Sinnett D., Pfau W., Labuda D. Mutat. Res. 516:2002;41.
88. Magagnotti C., Pastorelli R., Pozzi S., Andreoni B., Fanelli R., Airoldi L. Int. J. Cancer. 107:2003;878.
89. Magagnotti C., Orsi F., Bagnati R., Celli N., Rotilio D., Fanelli R., Airoldi L. Int. J. Cancer. 88:2000;1.
90. Reistad R., Rossland O.J., Latva-Kala K.J., Rasmussen T., Vikse R., Becher G., Alexander J. Food Chem. Toxicol. 35:1997;945.
91. Kulp K.S., Knize M.G., Malfatti M.A., Salmon C.P., Felton J.S. Carcinogenesis. 21:2000;2065.
92. Strickland P.T., Qian Z., Friesen M.D., Rothman N., Sinha R. Mutat. Res. 506-507:2002;163.
93. Sinha R., Rothman N., Mark S.D., Murray S., Levander O.A., Davies D.S., Lang N.P., Kadlubar F.F., Hoover R.N. Carcinogenesis. 16:1995;2859.
94. Kidd L.C., Stillwell W.G., Wishnok J.S., Skipper P.L., Ross R.K., Henderson B.E., Tannenbaum S.R. Cancer Epidemiol. Biomarkers Prev. 8:1999;439.
95. Stillwell W.G., Turesky R.J., Sinha R., Tannenbaum S.R. Cancer Res. 59:1999;5154.
96. Langouet S., Welti D.H., Kerriguy N., Fay L.B., Huynh-Ba T., Markovic J., Guengerich F.P., Guillouzo A., Turesky R.J. Chem. Res. Toxicol. 14:2001;211.